Evidence map›Paper›PMID 42690030›Full record

ArticlemSphere2026

Uncovering the mechanism of action of a historical antimicrobial against

Oluwatosin Qawiyy Orababa, Jessica Furner-Pardoe, Alexander Gale, Blessing Anonye, Joe Ratcliff, Natasha Reddy, Ramón Garcia Maset, Niamh E Harrington, Shajini Subhaskaran, Séamus Holden and 3 more

Abstract read
In one paragraph

Article in mSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Oluwatosin Qawiyy Orababa *School of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.ORCID 0000-0002-8905-9927
Jessica Furner-Pardoe *Warwick Medical School, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.
Alexander GaleSchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.
Blessing AnonyeSchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.ORCID 0000-0003-1619-5554
Joe RatcliffSchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.
Natasha ReddyWarwick Medical School, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.
Ramón Garcia MasetWarwick Medical School, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.
Niamh E HarringtonSchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.
Shajini SubhaskaranSchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.
Séamus HoldenSchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.
Stephen P DiggleSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, USA.
Christophe CorreSchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.
Freya HarrisonSchool of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom.ORCID 0000-0001-8449-5095

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products have provided most of our modern pharmacopeia, serving as active molecules or scaffolds for active molecules. Their use in drug development is often inspired by their traditional or historical medical use. For many decades, this discovery pipeline has focused on identifying a single molecule responsible for much of the biological activity of a "raw" natural product preparation (e.g., a whole-plant extract) and scoping this molecule for clinical potential. However, it is increasingly realized that historical/traditional remedies with significant biological activity may owe this activity to the combined action of multiple molecules. Concomitantly, microbiologists increasingly argue that effectively fighting antimicrobial-resistant infections will rely on combination therapies that combine multiple antimicrobials and/or adjuvant molecules. We previously reconstructed a complex historical remedy, Bald's eyesalve. Our reconstruction of this remedy had strong antibiofilm activity, which relied on the presence of multiple ingredients. Here, we report that Bald's eyesalve has multiple antibacterial effects on exemplar gram-positive (

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBiological ProductsStaphylococcus aureusBiofilmsMicrobial Sensitivity TestsAnti-Bacterial AgentsBiological ProductsAMRancientbioticsantibiotic mechanismsantivirulence mechanismsbiofilmnatural products

Identifiers

PMID42690030
PMCPMC13621861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.